When Frenkie de Jong injured his knee and chose not to go under the knife, the public debate lasted only a short time on medical grounds. Within days it had become something else: an expensive player who was allegedly refusing surgery against the advice of the medical staff. The player himself ended up refuting that, explaining that the decision had been reached jointly with the club doctors, and in passing also refuting the figures circulating about his salary. The clinical conversation had been swallowed up by the financial one.
What is striking is that this contamination was not entirely unjustified. In professional football, the decision to operate is rarely a purely medical calculation. A footballer's body is simultaneously an organism and a balance-sheet asset, and the two things respond to different logics that do not always point in the same direction.
It is worth starting with what the evidence says, because there are already surprises there. Orthopaedic surgeon Ian Harris published a book a decade ago with a provocative title, Surgery: The Ultimate Placebo, in which he argued that a large portion of elective orthopaedic surgery does not outperform a placebo in its outcomes. His argument rests on trials involving sham surgery: patients who received an incision and nothing more, and who recovered just as well as those who actually went under the knife. Meniscectomy for degenerative lesions and shoulder decompression are his most frequently cited examples.
The thesis has received serious criticism, and the main objection is pertinent here: Harris reasons about populations and the surgeon operates on specific individuals. But above all, his conclusions refer largely to degenerative pathologies in older patients, not to traumatic tears in twenty-five-year-old athletes. Applying them to football without qualification would be a mistake.
With that caveat, the picture in typical football injuries is more nuanced than convention suggests. For the anterior cruciate ligament, the KANON trial followed patients assigned to early surgery or rehabilitation for ten years and found that half of those in the conservative group never ended up needing the operation. Even so, in elite football the consensus remains to operate, because changes of direction and pivot-foot landings demand a stability that the musculature can rarely sustain on its own. For the Achilles tendon, meta-analyses have gradually brought the re-rupture rates for surgery and for functional immobilisation rehabilitation into line, though the elite still leans toward surgery to preserve explosive strength. In tendinopathies, eccentric loading work clearly beats the scalpel, which is reserved for cases that fail to respond after months of treatment. And for fifth metatarsal fractures the surgical consensus is absolute, because the area has almost no blood supply and the bone does not consolidate on its own.
In other words, there are injuries where the evidence is unequivocal and others where a genuine margin for decision exists. And it is precisely in that margin where factors that are not medical come into play.
The first is the cost of time. A sector report put at more than 730 million euros what the five major European leagues paid in one season in wages for injured players, with the Premier League absorbing almost half. Every day of absence is money leaving without any sporting return. The pressure to shorten timelines does not spring from anyone's bad faith: it springs from that bill.
The second is depreciation. A player's rights are recorded as an intangible asset that is amortised over the length of the contract, and his market value erodes with every week of inactivity. Econometric models built on market data place the average drop in a footballer's value at around eleven per cent when an absence exceeds one month. A long injury does not only cost wages: it reduces the value of the asset.
And the third is the most uncomfortable, because it is an incentive created by regulation itself. In Spain, the financial control rules allow a club to exceed its wage limit to register a replacement when a player suffers a certified long-term absence, with the threshold set at four months. For a club suffocating under financial fair play, a surgical intervention with predictable timelines guarantees crossing that threshold, whereas a conservative treatment of uncertain duration may leave the club without that release valve. The rule does not compel anyone to operate, but it introduces a preference where previously only clinical judgement should have existed.
There is also an incentive that pushes the player himself toward the operating theatre, and which tends to be overlooked. Contracts that have already been signed cannot be made conditional on passing a medical, so buying clubs scrutinise every detail before signing. A footballer who avoided an operation may find himself, two years later, with a scan that derails the most important transfer of his career.
In the face of all this, the final decision is legally his. Patient autonomy law makes informed consent an inalienable right, and no club can impose a procedure however much the wait costs them. What the club can do is suggest, insist, and create an atmosphere. That is why the independent second opinion has become routine at elite level: it is the means by which a player can verify the judgement of doctors who, however honest they may be, are paid by the club.
It is worth avoiding drawing a conspiracy where what exists is above all tension. In many cases medicine rules without question and the financial calculation is irrelevant. And there is an argument that points in the opposite direction to suspicion: precisely because a player is worth a hundred million, the medical departments of the big clubs are more cautious than in amateur sport, with constant monitoring and withdrawal at the first sign of overload. Protecting the asset also means not breaking it.
The broader trend, moreover, is moving toward operating less. Regenerative therapies, functional rehabilitation and strength work have been progressively displacing the scalpel in pathologies where it was once automatic.
What does not move is the calendar. The players' union has been documenting for years that more than half of elite players accumulate loads that its reports classify as excessive, and that injuries among those under twenty-one have worsened sharply. One can debate whether it is better to operate or to rehabilitate. It is harder to debate that the body needs a rest that the business does not provide for.
In the end, the question about the operating theatre almost always conceals another one. It is not only whether this injury heals better with surgery, but how long those who are paying can afford to wait.
